Max Chat
Company Analysis Physicians Realty Trust
1. Summary
Advantages
- Dividends (6.21%) are higher than the sector average (3.28%).
- The company's current efficiency (ROE=3.3%) is higher than the sector average (ROE=1.96%)
Disadvantages
- Price (17.38 $) is higher than fair price (4.27 $)
- The stock's return over the last year (-17.45%) is lower than the sector average (-6.16%).
- Current debt level 45.26% has increased over 5 years from 39.06%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Physicians Realty Trust | Real Estate | Index | |
|---|---|---|---|
| 7 days | 2.1% | 0% | -0.3% |
| 90 days | 2.4% | -10.8% | 17.4% |
| 1 year | -17.5% | -6.2% | 11.1% |
DOC vs Sector: Physicians Realty Trust has significantly underperformed the "Real Estate" sector by -11.29% over the past year.
DOC vs Market: Physicians Realty Trust has significantly underperformed the market by -28.58% over the past year.
Stable price: DOC is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: DOC with weekly volatility of -0.3356% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (17.38 $) is higher than the fair price (4.27 $).
Price is higher than fair: The current price (17.38 $) is 75.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (55.57) is lower than that of the sector as a whole (72.5).
P/E vs Market: The company's P/E (55.57) is lower than that of the market as a whole (61.84).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.49) is higher than that of the sector as a whole (-8.76).
P/BV vs Market: The company's P/BV (1.49) is lower than that of the market as a whole (20.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (5) is lower than that of the sector as a whole (8.18).
P/S vs Market: The company's P/S indicator (5) is lower than that of the market as a whole (15.97).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (13.92) is lower than that of the sector as a whole (153.35).
EV/Ebitda vs Market: The company's EV/Ebitda (13.92) is lower than that of the market as a whole (18.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 53.55% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (53.55%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-7.74%).
5.4. ROE
ROE vs Sector: The company's ROE (3.3%) is higher than that of the sector as a whole (1.96%).
ROE vs Market: The company's ROE (3.3%) is lower than that of the market as a whole (42.62%).
5.5. ROA
ROA vs Sector: The company's ROA (1.36%) is lower than that of the sector as a whole (2.97%).
ROA vs Market: The company's ROA (1.36%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (6.96%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.15%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 6.21% is higher than the average for the sector '3.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 6.21% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 6.21% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (326.88%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
